2630
K. C. BABU ET AL.
ACKNOWLEDGMENT
Financial support from the Inogent Laboratories Private Limited (A GVK
BIO Company) is gratefully acknowledged.
REFERENCES
1. Kakeya, H.; Morishita, M.; Koshino, H.; Morita, T.; Kobayashi, K.; Osada, H. Cytoxa-
zone: A novel cytokine modulator containing a 2-oxazolidinone ring produced by strepto-
myces sp. J. Org. Chem. 1999, 64, 1052.
2. Kakeya, H.; Morishita, M.; Kobinata, K.; Osono, M.; Ishizuka, M.; Osada, H. Isolation
and biological activity of a novel cytokine modulator, cytoxazone. J. Antibiot. 1999, 51,
1126.
3. Hamersak, Z.; Ljubovic, E.; Mercep, M.; Mesic, M.; Sunjic, V. Chemoenzymatic synthesis
of all four cytoxazone stereoisomers. Synthesis 2001, 13, 1989.
4. Miyata, O.; Asai, H.; Naito, T. A Concise synthesis of (ꢀ)-cytoxazone and its stereo-
isomers via imino 1,2-wittig rearrangement. Synlett 1999, 12, 1915
5. Madhan, A.; Ravi Kumar, A.; Venkateswara Rao, B. Stereoselective synthesis of
(ꢀ)-cytoxazone. Tetrahedron: Asymmetry 2001, 12, 2009.
6. Sakamoto, Y.; Shiraishi, A.; Seonhee, J.; Nakata, T. Stereoselective syntheses of cytoxa-
zone, a novel cytokine modulator, and its stereoisomers. Tetrahedron Lett. 1999, 40, 4203.
7. Seki, M.; Mori, K. Synthesis of (–)-cytoxazone, a novel cytokine modulator isolated from
Streptomyces sp. Eur. J. Org. Chem. 1999, 0, 2965.
8. Milicevic, S.; Matovic, R.; Saicic, R. N. Stereoselective synthesis of (ꢀ)-cytoxazone and
(þ)-epi-cytoxazone. Tetrahedron Lett. 2004, 45, 955.
9. Carter, P. H.; LaPorte, J. R.; Scherle, P. A.; Decicco, C. P. A new synthesis of cytoxazone
and its diastereomers provides key initial SAR information. Bioorg. Med. Chem. Lett.
2003, 13, 1237
10. (a) Miyata, O.; Koizumi, T.; Ninomiya, I.; Naito, T. New imino-wittig rearrangement of
benzyl and allyl hydroximates. J. Org. Chem. 1996, 61, 9078; (b) Miyata, O.; Iba, R.;
Hashimoto, J.; Naito, T. A convenient route to the furopyran core of dysiherbaine.
Org. Biomol. Chem. 2003, 1, 772; (c) Miyata, O.; Koizumi, T.; Asai, H.; Iba, R.; Naito,
T. Imino 1,2-wittig rearrangement of hydroximates and its application to synthesis of
cytoxazone. Tetrahedron 2004, 60, 3893–3914; (d) Miyata, O.; Hashimoto, J.; Iba, R.;
Naito, T. Preparation of optically active a -hydroxy oxime ether by diastereoselective
imino 1,2-Wittig rearrangement of hydroximates and its application to synthesis of
(þ)-cytoxazone. Tetrahedron Lett. 2005, 46, 4015.
11. Chandra Babu, K.; Raman, V.; Srinivas, K. S. V.; Satish, N.; Madhusudhan, G.;
Mukkanti, K. Asymmetric synthesis of (4S,5S)-2-oxo-4-phenyloxazolidine-5-carboxylic
acid using 1,2-addition of PhMgBr to N-sulfinimine derived from (R)-glyceraldehyde
acetonide and (S)-t-BSA. Tetrahedron: Asymmetry 2010, 21, 2619–2624.
12. (a) Evans, J. W.; Ellman, J. A. Stereoselective synthesis of 1,2-disubstituted b-amino
alcohols by nucleophilic addition to N-tert-butanesulfinyl a-alkoxyaldimines. J. Org.
Chem. 2003, 68, 9948–9957; (b) Morton, D.; Stockman, R. A. Chiral non-racemic sulfini-
mines: Versatile reagents for asymmetric synthesis. Tetrahedron. 2006, 62, 8869–8905.
13. (a) Davies, S. G.; Hughes, D. G.; Nicholson, R. L.; Smith, A. D.; Wright, A. Asymmetric
synthesis of (4R,5R)-cytoxazone and (4R,5S)-epi-cytoxazone. J. Org. Biomol. Chem. 2004,
2, 1549; (b) Paraskar, A. S.; Sudalai, A. Enantioselective synthesis of (L)-cytoxazone and
(þ)-epicytoxazone, novel cytokine modulators via Sharpless asymmetric epoxidation and
L-proline-catalyzed Mannich reaction. Tetrahedron 2006, 62, 5756; (c) George, S.; Narina,